Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm

GA Joice, JL Liu, AL Burnett - BJU international, 2021 - Wiley Online Library
Objectives To examine the current molecular therapeutics in the medical treatment of
recurrent ischemic priapism (RIP). To propose a stepwise clinical management paradigm for …
被引用次数：25 相关文章

Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm

GA Joice, JL Liu, AL Burnett - BJU international, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives To examine the current molecular therapeutics in the medical treatment of
recurrent ischemic priapism (RIP). To propose a stepwise clinical management paradigm for …

Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm.

GA Joice, JL Liu, AL Burnett - BJU International, 2021 - search.ebscohost.com
Objectives: To examine the current molecular therapeutics in the medical treatment of
recurrent ischemic priapism (RIP). To propose a stepwise clinical management paradigm for …

Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm.

GA Joice, JL Liu, AL Burnett - BJU International, 2021 - europepmc.org
Objectives To examine the current molecular therapeutics in the medical treatment of
recurrent ischemic priapism (RIP). To propose a stepwise clinical management paradigm for …

Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm

GA Joice, JL Liu, AL Burnett - BJU International, 2021 - pure.johnshopkins.edu
Objectives: To examine the current molecular therapeutics in the medical treatment of
recurrent ischemic priapism (RIP). To propose a stepwise clinical management paradigm for …